Vivos Therapeutics (VVOS) Current Taxes (2023 - 2026)
Vivos Therapeutics' (VVOS) quarterly Current Taxes came in at $877000.0 in Q1 2026, up 64.54% year-on-year from $533000.0 in Q1 2025, and up 9.76% on a QoQ basis from $799000.0 in Q4 2025.
Vivos Therapeutics (VVOS) Current Taxes (2023 - 2026) Analysis & Trends
Vivos Therapeutics (VVOS) has 4 years of Current Taxes data on file, last reported at $877000.0 in Q1 2026.
- On a quarterly basis, Current Taxes rose 64.54% year-over-year to $877000.0 in Q1 2026; TTM through Mar 2026 was $877000.0, a 64.54% increase from a year earlier, with the FY2025 full-year figure at $799000.0, up 66.11% from the prior year.
- Current Taxes for Q1 2026 stood at $877000.0, up from $799000.0 in the prior quarter.
- Over the last five years, Current Taxes for VVOS reached as high as $877000.0 in Q1 2026 and fell as low as $327000.0 in Q4 2023.
- Historically, Current Taxes has averaged $625000.0 across 4 years, with a median of $631000.0 in 2025.
- Across the five-year window, Current Taxes soared 47.09% in 2024 and soared 66.11% in 2025, its largest moves.
- Year by year, Current Taxes stood at $327000.0 in 2023, then surged by 47.09% to $481000.0 in 2024, then surged by 66.11% to $799000.0 in 2025, then gained by 9.76% to $877000.0 in 2026.
- Per Business Quant data, the three most recent Current Taxes figures were $877000.0 in Q1 2026, $799000.0 in Q4 2025, and $727000.0 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 598.00 Mn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | 476.00 Mn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | 914.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | - |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | - |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | 231.81 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | - |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | 194.00 Mn |
| 10 | Vivos Therapeutics | 3.62 Mn | 1.38 Mn | 3.06 Mn | 877,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 877,000.00 |
| Dec 31, 2025 | 799,000.00 |
| Sep 30, 2025 | 727,000.00 |
| Jun 30, 2025 | 631,000.00 |
| Mar 31, 2025 | 533,000.00 |
| Dec 31, 2024 | 481,000.00 |
| Dec 31, 2023 | 327,000.00 |